This trial is looking at what the best dose of radiation is to treat low grade follicular lymphoma while minimizing side effects.
- Follicular Lymphoma
1 Primary · 1 Secondary · Reporting Duration: 1 month and 3 month
1 Treatment Group
12 Gy in 6 daily fractions
1 of 1
27 Total Participants · 1 Treatment Group
Primary Treatment: 12 Gy in 6 daily fractions · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this experiment actively seeking participants?
"Yes, clinicaltrials.gov affirms that this medical trial is currently seeking participants. The initial post was on February 28th 2022 and the most recent update took place on March 10th 2022." - Anonymous Online Contributor
What is the number of participants in this investigation?
"Affirmative. Clinicaltrials.gov records that this research is actively seeking participants, with the initial post being made on February 28th 2022 and revised on March 10th of the same year. 27 subjects need to be enrolled from one site for the study's completion." - Anonymous Online Contributor
Does the FDA sanction 12 Gy split into six daily fractions?
"A score of 2 was assigned to 12 Gy in 6 daily fractions due to the lack of evidence supporting efficacy, but some data indicating safety." - Anonymous Online Contributor